Cargando…

Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness

Oseltamivir phosphate is a widely used anti-influenza sialidase inhibitor. Sialylation, governed by sialyltransferases and sialidases, is strongly implicated in the oncogenesis and progression of breast cancer. In this study we evaluated the biological behavior of canine mammary tumor cells upon ose...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Joana T., Santos, Ana L., Gomes, Catarina, Barros, Rita, Ribeiro, Cláudia, Mendes, Nuno, de Matos, Augusto J., Vasconcelos, M. Helena, Oliveira, Maria José, Reis, Celso A., Gärtner, Fátima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388625/ https://www.ncbi.nlm.nih.gov/pubmed/25850034 http://dx.doi.org/10.1371/journal.pone.0121590

Ejemplares similares

Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
por: Figueira, Ana Catarina, et al.
Publicado: (2014)

Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
por: de Oliveira, Joana T., et al.
Publicado: (2015)

Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression
por: Pinho, Salomé S, et al.
Publicado: (2007)

Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study
por: Santos, Andreia A, et al.
Publicado: (2013)

Synthesis and Biological Evaluation of NH(2)-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
por: Hu, Yaping, et al.
Publicado: (2019)

P-Cadherin Expression in Feline Mammary Tissues
por: Figueira, Ana Catarina, et al.
Publicado: (2012)

Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
por: Tao, Jiaye, et al.
Publicado: (2022)

Discrimination of Benign and Malignant Lesions in Canine Mammary Tissue Samples Using Raman Spectroscopy: A Pilot Study
por: Dantas, Diana, et al.
Publicado: (2020)

A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
por: Bloom, Jesse D., et al.
Publicado: (2011)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan
por: Ghosh, Gopal C., et al.
Publicado: (2010)

Canine Mammary Mixed Tumours: A Review
por: Dantas Cassali, Geovanni, et al.
Publicado: (2012)

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses
por: Duan, Susu, et al.
Publicado: (2014)

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors
por: Wang, Pengfei, et al.
Publicado: (2021)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
por: Xu, Zhichao, et al.
Publicado: (2022)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2008)

Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
por: Seifert, Stephanie, et al.
Publicado: (2013)

Design, Synthesis, Biological Evaluation and In Silico Studies of Pyrazole-Based NH(2)-Acyl Oseltamivir Analogues as Potent Neuraminidase Inhibitors
por: Ye, Jiqing, et al.
Publicado: (2021)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype
por: Freitas, Daniela, et al.
Publicado: (2019)

Decentralization of oseltamivir phosphate as a way to prevent or aggravate cases of Flu Syndrome (FS) and Severe Acute Respiratory Syndrome (SARS)
por: Marques Da Costa, J., et al.
Publicado: (2020)

An immunohistochemical study of canine spontaneous gastric polyps
por: Amorim, Irina, et al.
Publicado: (2014)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor
por: Park, Hyoung-Min, et al.
Publicado: (2020)

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
por: Gulati, Shelly, et al.
Publicado: (2009)

Molecular Plasticity of E-Cadherin and Sialyl Lewis X Expression, in Two Comparative Models of Mammary Tumorigenesis
por: Pinho, Salomé S., et al.
Publicado: (2009)

Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia
por: Aziz, Shahir, et al.
Publicado: (2020)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

Detection of cancer stem cells by immunohistochemistry of canine mammary neoplasias
por: Magalhães, Geórgia Modé, et al.
Publicado: (2013)

Prognostic phenotypic classification for canine mammary tumors
por: Varallo, Giovanna Rossi, et al.
Publicado: (2019)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Oseltamivir Resistance in Influenza A(H6N2) Caused by an R292K Substitution in Neuraminidase Is Not Maintained in Mallards without Drug Pressure
por: Gillman, Anna, et al.
Publicado: (2015)

A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
por: Gao, Guanghua, et al.
Publicado: (2019)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016)

Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support
por: Wildschut, Enno D., et al.
Publicado: (2010)

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
por: Gameiro, Andreia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_13gftehfrii8i6qiat5blg9ro1